CompletedNCT02918318
Official study titleA Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Subjects With Treatment Resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including AkitaDepressionMedication studyAges 20–64
- Countries
- Japan
- Sponsor
- Janssen Pharmaceutical K.K.
CompletedNCT06275217
Official study titleThe Effects of a Mindful Yoga Program on Mood Symptoms and Stress for Postpartum Women With Depressive Symptoms: a Randomized Controlled Clinical Trial
This study has finished and is no longer accepting participants.
In Hong KongDepressionBehavioural studyAges 18–60
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
CompletedNCT00844922
Official study titleDouble-blind, Placebo-controlled Trial Investigating the Safety of Re-exposure to 900 mg of Org 34517, Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features), Who Participated in Trial 28130
This study has finished and is no longer accepting participants.
Location not clearly listedDepression, SchizophreniaMedication studyAges 18–75
- Countries
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT05701345
Official study titleProspective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including IlsanDepressionDevice studyAges 19–64
- Countries
- South Korea
- Sponsor
- Omni C&S
CompletedACTRN12610001071011
Official study titleInvestigating predictors of the antidepressant efficacy of Transcranial Magnetic Stimulation
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 18–75
- Countries
- Australia
- Sponsor
- Professor Paul Fitzgerald
CompletedACTRN12610000564055
Official study titleIn patients with unipolar affective disorder who have failed to respond to an adequate trial of an antidepressant, is a switching strategy (from Citalopram to Despiramine or from Desipramine to Citalopram) more effective than a non-switching strategy in terms of response and remission rates?
This study has finished and is no longer accepting participants.
In BelgiumDepressionInterventional studyAges 18–90
- Countries
- Belgium
- Sponsor
- Group for the Study of Resistant Depression
Active Not RecruitingNCT06002204
Official study titleStudying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression (SHAKTI)
This study is no longer accepting new participants.
In DallasDepression, BipolarityObservational studyAges 10+
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center